ArticleMolecular cancer therapeutics2020

An Orally Available Tubulin Inhibitor, VERU-111, Suppresses Triple-Negative Breast Cancer Tumor Growth and Metastasis and Bypasses Taxane Resistance.

Shanshan Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.